entertainment -WSS

entertainment

author：comprehensive 2025-09-06 02:11:00 - browse：94274

A person uses continuous glucose remote monitor with his phone — health tech coverage from STAT — Adobe

A diabetes diagnosis was not what Jason had in mind when he set out on a cross-country road trip with his family in the fall of 2021. He had been heavy since he was a kid, but he always had felt pretty healthy — until getting home to the San Francisco Bay Area, when he started to notice his body doing strange things.

“It kind of came out of nowhere,” said Jason, who asked to keep his last name private. All of a sudden, he had to get up to pee five times in a night. Just a few weeks after his trip, he was having a hard time walking around the block. He went to get checked out at the Palo Alto Medical Foundation, and on a Thursday night in November, the blood test results popped up in his patient portal: He had type 2 diabetes.

“I was freaked out,” he said. “I was in legitimately bad shape.” It would take months to see an endocrinologist. So that day, he signed up to try a novel, telehealth-based approach for managing diabetes with a young company called Steady Health. Jason knew the company through his Bay Area startup connections — as well as Carbon Health, the primary care startup, reportedly valued at more than $3 billion, that had recently acquired Steady.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Kale crackers and hibiscus tea: My five days on a 'fasting diet'

WSS

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Kenai launches with $82 million for Parkinson’s stem cell therapy

In search for therapies for solid tumors, companies turn to claudin

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Trump Organization, Michael Cohen agree to settle million

Pfizer highlights cancer drugs it thinks could reignite investor interest

hotspot

entertainment

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Malaria cases in Florida and Texas: Here’s what you need to know

Hey, doctors: Don't be no

Anesthesiologist group: stop taking Ozempic before surgery

New chart reveals military’s vast involvement in Operation Warp Speed

How to save PrEP access — and even expand it

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

As demand for Covid shots wanes, Moderna seeks its next success

EMA weighs against approval for Mirati's lung cancer drug

knowledge

Reframing the conversation around gain

A Q&A with Aletha Maybank, AMA’s chief health equity officer

What is the Turing Test that determines if computers can think?

Hey, doctors: Don't be no

In search for therapies for solid tumors, companies turn to claudin

Biotech companies concerned about China biosecurity crackdown

leisure time

hotspot

focus

leisure time